Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MIRM

Mirum Pharmaceuticals, Inc.

Healthcare | Biotechnology
$102.99 as of 2026-09-05 16:27 UTC
Market Cap$6.3B
Volume120.1K
EPS (TTM)$-0.47

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is a $6.3B biotechnology company trading at $102.99. Figures from SEC EDGAR and market feeds; updated 2026-09-05 16:27 UTC.

What Mirum Pharmaceuticals, Inc. does

Mirum Pharmaceuticals is a biopharmaceutical company focused on rare diseases with three approved medicines: Livmarli for cholestatic pruritus and progressive familial intrahepatic cholestasis, Cholbam for bile acid synthesis disorders and peroxisomal disorders, and Ctexli for cerebrotendinous xanthomatosis. The company markets these medicines in the United States, Canada, and select European countries through its own commercial team, and has entered into license and distribution agreements for additional territories.

Summarized from Mirum Pharmaceuticals, Inc.’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$102.99
Market cap$6.3B
Volume120.1K shares
Valuation
EPS (TTM)$-0.47
Price/book19.96×

Revenue, margins & earnings

FY2021: net loss $84M on revenue $19M$19MFY2021FY2022: net loss $136M on revenue $77M$77MFY2022FY2023: net loss $163M on revenue $186M$186MFY2023FY2024: net loss $88M on revenue $337M$337MFY2024FY2025: net loss $23M on revenue $521M$521MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-03
  • 2026-09-03Howe JolandaSVP, GLOBAL CONTROLLERSELL-658$65.8K
  • 2026-09-03Peetz ChristopherCHIEF EXECUTIVE OFFICERM30,000$88.1K
  • 2026-09-03Peetz ChristopherCHIEF EXECUTIVE OFFICERSELL-8,312$815.2K
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does Mirum Pharmaceuticals, Inc. do?

Mirum Pharmaceuticals, Inc. is a biotechnology company, listed on NASDAQ as MIRM.

What is MIRM's valuation?

MIRM trades at $102.99, as of 2026-09-05.

When did MIRM last file with the SEC?

Mirum Pharmaceuticals, Inc.'s most recent SEC filing on record is a 10-Q filed 2026-08-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-05 16:27 UTC. This page is also available as JSON at /api/data?ticker=MIRM and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MIRM and 5,000+ tickers.

Create a free account — keep MIRM
For your agent
GET /api/data?ticker=MIRM

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt